All players in this sector are in the same boat, I've read all their HY reports, it is hard to generate any meaningful revenue when all are essentially in the product development stage, awaiting trials or stability testing.
All investors of each company will claim and support how great their products are, how well sales are going to go, but, honestly, no one knows, it is all speculation, sales revenue once the products are released at commercial scale to the market will determine who is the winner.
However, I do have some faith in the IHL leadership, especially Sud Agarwal. He has a proven track record, built businesses from the ground up, understands all aspects of business, particularly the financials and highly regard by most doctors in the market (with a few haters). He is just an AGILE guy that gets stuff done!
For most of us, it is a low cost of entry with exponential upside.
June 2021 will reveal if this sector is a complete bust or that we all got in really early and will be reaping some serious returns.
IHL Price at posting:
5.2¢ Sentiment: Hold Disclosure: Held
